Non-voluntary licensing of antivirals under patent: options the Australian Government should consider in light of a potential bird flu pandemic.
In the face of a potential bird flu pandemic, Australian Federal Health Minister, Tony Abbott, has recently dismissed expert advice that the government should begin, or even publicly consider, authorising generic manufacturers to produce antivirals, such as Tamiflu and Relenza, under patent via non-voluntary licensing methods. This is despite the fact that the demand for antivirals in Australia, and throughout the world, cannot be met by manufacturers under the control of limited patent owners alone. This article proposes that Australian patent law, which allows for non-voluntary licensing when it comes to important public health issues that affect Australian citizens, is relevant in meeting the demand for increased antiviral treatments during a possible bird flu pandemic, domestically and abroad. It argues that the Australian Government must go beyond what is currently being done and investigate and pursue such options.
Davies
Tim
T
University of Tasmania, Faculty of Law, Hobart, Australia. tim_d@utas.edu.au
D000081:Acetamides / Q000600:supply & distribution; D000818:Animals; D000998:Antiviral Agents / Q000600:supply & distribution*; D001315:Australia; D001717:Birds; D016568:Drugs, Generic / Q000600:supply & distribution*; D006146:Guanidines / Q000600:supply & distribution; D006301:Health Services Needs and Demand; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000187:drug effects; D005585:Influenza in Birds; D007251:Influenza, Human / Q000188:drug therapy*; D007880:Legislation, Drug; D053139:Oseltamivir; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011634:Public Health / Q000331:legislation & jurisprudence*; D011714:Pyrans / Q000600:supply & distribution; D012794:Sialic Acids / Q000600:supply & distribution; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D016568:Drugs, Generic; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D053243:Zanamivir